The New Era of Preventive Cardiology: Applying PCSK9 Inhibitor Therapeutics to Prevent Heart Attack and Stroke

Overview

This live symposium held in conjunction with the National Lipid Association 2018 Scientific Sessions will outline the role of PCSK9 inhibitor therapeutics in preventing heart attack and stroke in a new era of preventive cardiology. The expert faculty will review risk stratification for patients with cardiovascular disease (CVD).  Cardiovascular outcomes data from ODYSSEY and FOURIER PCSK9 inhibitor clinical trials will be analyzed, utilizing an interactive panel format to translate evidence-based medicine to clinical decision making. The faculty will evaluate best practices for optimally managing preventive cardiology with PCSK9 inhibitor therapeutics.

Agenda

2:15 – 2:30 pm – Welcome and Introductions

2:30 – 2:40 pm – Accurate Assessment of CVD Risk

2:40 – 2:45 pm – Interactive Panel Discussion

2:45 – 2:55 pm – ODYSSEY Outcomes Trial Data

2:55 – 3:05 pm – FOURIER Trial Data

3:05 – 3:15 pm – Interactive Panel Discussion

3:15 – 3:25 pm – Applying Advanced Lipid Science to Clinical Practice

3:25 – 3:30 pm – Interactive Panel Discussion and Conclusion

Target Audience

This activity is designed to meet the needs of cardiologists, lipidologists, primary care physicians, nurse practitioners, nurses, pharmacists, dietitians and other healthcare professionals involved in the management of patients with or at risk for cardiovascular disease.

Learning Objectives

1. Recognize the accurate assessment of cardiovascular disease risk across all patient populations
2. Analyze the clinical trial and real world data that supports the role of PCSK9 therapeutics for the prevention of heart attack and stroke
3. Appraise the use of PCSK9 therapeutics through case studies
4. Discuss strategies to improve the knowledge, skills or performance of the healthcare team

Location

JW Marriott Las Vegas – Marquis Ballroom 4-8
21 N Rampart Blvd, Las Vegas, NV 89145

Date/Time

Thursday, April 26^th, 2018
Registration and Refreshments: 2:15 pm – 2:30 pm
CME/CE Program: 2:30 pm – 3:30 pm

Registration Fee

There is no fee for this educational activity.

Accreditation Statement

 

CME credit provided by the National Lipid Association

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and AcademicCME, LLC. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement 

The National Lipid Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Physician Assistants

NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Dietitians

The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1 continuing professional education unit (CPEU) for completion of this program/ materials. CDR Accredited Provider #NL002.

Pharmacist

Universal Activity Number – J0007192-9999-18-007-L01-P (Application)

This Activity has been approved for 1.00 contact hour (.1 CEU) of the Accreditation Council for Pharmacy Education.

Nursing

The maximum number of hours awarded for this CE activity is 1.0 contact hour. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Activity Type

Live, Application

Criteria for Success

Statements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme. For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

Commercial Support

Full notification of commercial support will be provided in the activity syllabus.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc.). Please contact AcademicCME prior to the live event at [email protected].   This activity is jointly provided by the National Lipid Association in collaboration with AcademicCME, LLC.

CE Inquiries/Special Needs

For all CE inquiries or special needs, please contact: [email protected] or 610.687.3300.

—————————–

This is an independent satellite CME/CE symposium held in conjunction with the National Lipid Association 2018 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.

Chair:

Alan S. Brown, MD
Director, Division of Cardiology
Advocate Lutheran General Hospital
President-Elect, National Lipid Association
Co-Director, Cardiology Service Line
Advocate Medical Group
Clinical Associate Professor
Loyola Stritch Medical School
Park Ridge, Illinois

Faculty:

Robert P. Giugliano, MD, SM
Physician, CV Medicine
Brigham and Women’s Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Peter H. Jones, MD
Center for Cardiovascular Disease Prevention
Methodist DeBakey Heart and Vascular Center
Baylor College of Medicine
Houston, Texas

Daniel E. Soffer, MD
Clinical Associate Professor of Medicine
University of Pennsylvania
Internal Medicine and Preventive Cardiology
University of Pennsylvania Health System
Philadelphia, Philadelphia

James A. Underberg, MD, MS
Lipidology & Cardiovascular Disease Prevention
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
President, National Lipid Association
New York, New York